SHILLONG, Aug 9: Former NEIGRIHMS Director Dr. DM Thappa revealed that the Central Bureau of Investigation (CBI) is seeking approval from the Ministry of Health and Family Welfare for proceeding against Cardiology head from the institute Dr. Animesh Mishra.
He informed that CBI was investigating the implant scam and assets created by HOD Cardiology, Dr. Animesh Mishra for disruption of cath lab surgeries in May 2019.
An amount of 32 lakh rupees stents, pacemakers and other surgical implants from Sanjo Pharmacy, which is a private pharmacy run by the wife of a technician in radiodiagnosis department’s were reportedly seized.
The former NEIGRIHMS director said that the department of orthopaedics and radiology are also allegedly under the scrutiny of the intelligence agency and Dr. Mishra has been visiting the CBI office in regards to the case.
He alleged that Dr. Mishra was reportedly asking Sanjo pharmacy to visit Cath lab in cardiology department on daily basis to supply stents, pacemakers and implants at higher prices to run a private syndicate to derive benefits and create assets out of proportion of his income.
“This syndicate had been working for last 10-12 years as per the statements of DM cardiology students available you tube videos uploaded. His other two colleagues Dr. Manish Kapoor, Associate Professor and Dr. Amit Malviya, Assistant Professor were equal partners in this implant scam in NEIGRIHMS,” Dr. Thappa alleged.
The Former NEIGRIHMS Director, who is currently a Professor Senior Scale, Dermatology and STD Department in JIPMER, informed that he was shown the door for acting as the whistle blower to the corruption in the institute.
“AMRIT pharmacy was by passed which is supposed to supply these items at subsidised rates to hospital patients. Despite bringing this into notice of Ministry of Health and Family Welfare, Nirman Bhavan, New Delhi from 2017 to 2020, Director was asked to have a cordial relationship with Dr. Animesh Mishra,” he informed.
“Earlier the Institute’s self-run pharmacy was closed in 2016-17 to open private vendor “Life Care Pharmacy” in the institute premises with the help of current Deputy Director Administration (DDA) Shri. David T Umdor (against the advice of the Director In charge Dr. Prithwis Bhattacharyaa). Now AMRIT pharmacy is being targeted and being closed with the help of private pharmacy lobby and DDA. The nexus between various parties is deep to be scrutinized by Central Bureau of Investigations,” Dr. Thappa alleged.
He informed that following intervention from the Meghalaya High Court on April 2019, cardiology department started utilising the stents and other accessories from AMRIT pharmacy, but pacemakers continued to be procured from private parties outside NEIGRIHMS authorised pharmacies.
“Cath lab has been put at a cost of Rs. 10 crore rupees with annual maintenance of Rs. 25-26 lakh rupees,” Dr Thappa stated.
He added that there is another cath lab which is mobile and is not being used even when fixed cath lab goes out of order.
“These assets institute had created for the benefits of the public but still public is paying price for stenting which is higher than even corporate sector,” Dr. Thappa informed.